You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pralatrexate

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Pembrolizumab
  • Pralatrexate
  • Duarte, California
  • +2 more
Aug 15, 2022

Lymphoma, B-Cell Trial in United States (Pralatrexate, Vitamin B12, Folic Acid)

Completed
Has Results
  • Lymphoma, B-Cell
  • Pralatrexate
  • +2 more
  • Beverly Hills, California
  • +10 more
Oct 7, 2021

PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

Recruiting
  • PTCL
  • Long Beach, California
  • +2 more
Mar 1, 2022

Lymphoma Trial in New York (pralatrexate)

Completed
Has Results
  • Lymphoma
  • pralatrexate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 20, 2021

NSCLC Trial in Worldwide (Pralatrexate, Erlotinib, Vitamin B12)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Pralatrexate
  • +3 more
  • Bakersfield, California
  • +46 more
Feb 8, 2021

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

Cutaneous T-cell Lymphoma Trial in United States (Vitamin B12, Folic Acid, Pralatrexate)

Completed
  • Cutaneous T-cell Lymphoma
  • Vitamin B12
  • +2 more
  • Duarte, California
  • +9 more
Jan 2, 2020

Refractory Peripheral T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Beijing (pralatrexate, Vitamin B12 and folic acid)

Completed
Has Results
  • Refractory Peripheral T-Cell Lymphoma
  • Relapsed T-Cell Lymphoma
  • pralatrexate
  • Vitamin B12 and folic acid
  • Beijing, China
    Beijing Cancer Hospital
Sep 17, 2019

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Solid Tumor Trial in Omaha (drug, other, genetic)

Completed
Has Results
  • Unspecified Adult Solid Tumor, Protocol Specific
  • pralatrexate
  • +9 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Jul 13, 2018

Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma Trial in United States (drug,

Completed
Has Results
  • Anaplastic Large Cell Lymphoma
  • +3 more
  • Scottsdale, Arizona
  • +8 more
May 23, 2018

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (carboplatin, pralatrexate, Folic Acid)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Dec 20, 2017

Pralatrexate for Relapsed or Refractory Peripheral T-cell

Completed
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Pralatrexate
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
  • +1 more
Nov 23, 2017

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma, Gastric Adenocarcinoma Trial in Buffalo,

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
  • +1 more
Nov 14, 2017

Adult T-cell Leukemia-Lymphoma Trial in Worldwide (KW-0761, Pralatrexate, gemcitabine plus oxaliplatin)

Completed
Has Results
  • Adult T-cell Leukemia-Lymphoma
  • KW-0761
  • +3 more
  • Los Angeles, California
  • +19 more
Aug 21, 2018

Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,

Completed
Has Results
  • Relapsed Peripheral T-Cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma
  • Birmingham, Alabama
  • +151 more
Jul 6, 2018

Peripheral T Cell Lymphoma, Progression, Disease Trial in Taipei (Pralatrexate)

Unknown status
  • Peripheral T Cell Lymphoma
  • Progression, Disease
  • Pralatrexate
  • Taipei, Taiwan
    Ntional Taiwan University Hospital
May 10, 2017

Multiple Myeloma Trial in Stanford (velcade, Pralatrexate)

Completed
  • Multiple Myeloma
  • Stanford, California
    Stanford University School of Medicine
Jul 5, 2016

Advanced Cancers, Solid Tumors Trial in Houston (Erlotinib, Pralatrexate)

Completed
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 1, 2016

Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus

Completed
Has Results
  • Adenocarcinoma of the Esophagus
  • +4 more
  • pralatrexate
  • +3 more
  • Columbus, Ohio
    Ohio State University
Apr 25, 2016

Solid Tumor Trial in New York (pralatrexate, probenecid)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 25, 2013

Lung Cancer Trial in New York (pralatrexate)

Completed
  • Lung Cancer
  • pralatrexate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 18, 2013